DMKJ
PSTX

David M. Knott Jr’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

David M. Knott Jr’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-140,921
Closed -$248K – 156
2023
Q2 		$248K Hold
140,921
– – 0.1% 63
2023
Q1 		$434K Sell
140,921
-27,918
-17% -$167K 0.17% 59
2022
Q4 		$895K Buy
168,839
+17,553
+12% +$80.2K 0.34% 46
2022
Q3 		$534K Buy
+151,286
New +$500K 0.22% 69
2022
Q1 		– Sell
-19,566
Closed -$133K – 152
2021
Q4 		$133K Buy
+19,566
New +$133K 0.05% 97

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

David M. Knott Jr's PSTX Position: Q3 2023 in Review

David M. Knott Jr sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q3 2023, closing a stake of 140,921 shares — an estimated $248K sold.

David M. Knott Jr first reported a position in PSTX in Q4 2021 and held it in 5 quarters. The position peaked at $895K in Q4 2022. 86 funds tracked by Wall St. Rank hold PSTX as of Q3 2023.

  • David M. Knott Jr reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • David M. Knott Jr sold 140,921 Poseida Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $248K.
  • David M. Knott Jr first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • David M. Knott Jr's Poseida Therapeutics, Inc. Common Stock position peaked at $895K in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q3 2023.

Based on David M. Knott Jr's 13F filing for Q3 2023, filed 13 Nov 2023.